Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.
Shareholders of Kimberly-Clark will own about 54% of the combined company. Kenvue shareholders will own about 46% in what is one of the largest corporate takeovers this year. The deal must still be approved by the shareholders of both companies.
The combined company will have a huge stable of household brands under one roof, putting Kenvue’s Listerine mouthwash and Band-Aid side-by-side with Kimberly-Clark’s Cottonelle toilet paper, Huggies and Kleenex tissues. It will also generate about $32 billion in annual revenue.
Kenvue has spent a relatively brief period as an independent company, having been spun off by Johnson & Johnson two years

 WISC-TV Channel 3000

 CBS DFW
 ABC 7 Chicago Health
 Bloomberg TV
 Reuters US Business
 Omak Okanogan County Chronicle
 Santa Maria Times Local
 Reuters US Economy
 Cache Valley Daily
 CNN
 People Top Story
 Deadline Business
 Post Register
 Atlanta Black Star Entertainment